Lotus Eye Hospital and Institute Ltd
Ticker: LOTUSEYE
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
125.03
Market Cap
260.02
Debt/Equity
0.0572
ROE %
1.239
PB
4.3336
Promoter %
40.638
Pledge %
0.000
1Y Rev Growth %
2.726
5Y Rev Growth %
4.166
NP Margin %
1.455
NP Margin 5Y Avg %
5.612
Trading Reference
1M Return %
2.293
6M Return %
53.430
1Y Return %
79.357
% Away 52W High
11.333
% Away 52W Low
127.369
Daily Volume
34686
Investment Verdict
Risky
Score 49/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 48/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Lotus Eye Hospital shows steady growth in the healthcare sector, driven by increasing demand for eye care services.
✅ Positives
- Strong revenue growth over the past few years
- Expanding network of hospitals and clinics
- Experienced management team with industry expertise
⚠️ Negatives
- High competition in the healthcare sector
- Regulatory challenges affecting operations
- Dependence on a limited range of services
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
B
Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals has potential but faces significant challenges in growth and profitability metrics.
View details
U
U. Y. Fincorp Ltd
U. Y. Fincorp Ltd is facing several challenges, including inconsistent growth and profitability metrics, which make it a risky investment at this time.
View details
S
Sugs Lloyd Ltd
Sugs Lloyd Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bimetal Bearings Ltd
Bimetal Bearings Ltd shows decent potential but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
P
Precision Electronics Ltd
Precision Electronics Ltd shows potential but faces several challenges that could impact future performance. Investors should proceed with caution.
View details
C
Chemkart India Ltd
Chemkart India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vaarad Ventures Ltd
Vaarad Ventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Delphi World Money Ltd
Delphi World Money Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Competent Automobiles Company Ltd
Competent Automobiles Company Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
K
KCK Industries Ltd
KCK Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shivalic Power Control Ltd
Shivalic Power Control Ltd presents a risky investment opportunity with several concerns in growth consistency and market sentiment.
View details
P
Positron Energy Ltd
Positron Energy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Chembond Material Technologies Ltd
Chembond Material Technologies Ltd shows potential for growth and stability, but investors should be cautious of execution risks and governance concerns.
View details
K
Kapston Services Ltd
Kapston Services Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
GLEN Industries Ltd
GLEN Industries Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
T
Trishakti Industries Ltd
Trishakti Industries Ltd presents a risky investment opportunity due to inconsistent growth and profitability metrics, alongside concerns in governance and market sentiment.
View details
Business Overview
Lotus Eye Hospital and Institute Ltd is a premier healthcare facility dedicated to providing comprehensive eye care services across India. Catering to patients of all ages, the hospital specializes in advanced treatments and surgeries for various eye conditions. With a commitment to excellence, Lotus Eye Hospital combines state-of-the-art technology with compassionate care, ensuring optimal outcomes for its patients. As a trusted name in ophthalmology, it plays a crucial role in enhancing the quality of life through vision correction and eye health education.
- Leading provider of eye care in India
- Specialized treatments for all age groups
- State-of-the-art technology and facilities
- Experienced and compassionate medical team
- Focus on patient education and awareness
- Commitment to improving vision and quality of life
Investment Thesis
Lotus Eye Hospital presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital healthcare services, and attractive valuation compared to its peers. These factors position the company for robust future performance in the expanding healthcare sector.
- Strong promoter group with a proven track record in healthcare.
- Growing demand for digital services enhances revenue streams.
- Attractive valuation metrics compared to industry peers.
- Strategic expansion plans to capture market share.
- Robust financial health and consistent profitability.
Opportunity vs Risk
Opportunities
- Growing demand for eye care services
- Expansion into tier-2 cities
- Partnerships with insurance providers
- Technological advancements in treatments
Risks ⚠️
- Regulatory changes affecting healthcare
- High competition in the sector
- Economic downturn impacting discretionary spending
- Dependence on skilled professionals
Peer Perspective
Lotus Eye Hospital trades at a discount compared to peers like Dr. Agarwal's Eye Hospital and Narayana Nethralaya, primarily due to slower growth. A rerating could occur if it achieves consistent margin stability and accelerates patient acquisition.
Future Outlook
Lotus Eye Hospital and Institute Ltd is well-positioned for growth, driven by increasing demand for eye care services; however, successful execution of expansion plans and effective cost management will be crucial to achieving long-term profitability.
AI FAQs for Retail Users
- Q: What services does Lotus Eye Hospital provide?A: Lotus Eye Hospital specializes in eye care services, including surgeries, diagnostics, and treatments for various eye conditions.
- Q: Is Lotus Eye Hospital listed on stock exchanges?A: Yes, Lotus Eye Hospital is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in India.
- Q: What factors can affect Lotus Eye Hospital's stock price?A: Factors include financial performance, industry trends, regulatory changes, and overall market conditions.
- Q: How can I invest in Lotus Eye Hospital shares?A: You can invest through a brokerage account by buying shares on BSE or NSE.
- Q: What is the company's growth strategy?A: The company focuses on expanding services, enhancing technology, and increasing patient outreach to drive growth.
📊 Stock Investment Checklist (100 Points)
Lotus Eye Hospital and Institute Ltd • Updated: 2025-09-17 03:22:44
-
10BusinessHighThe healthcare sector is growing, but competition is increasing.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow issues.
-
8ValuationHighValuation metrics are above industry averages.
-
7BalanceHighDebt levels are manageable, but liquidity is tight.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about disclosures.
-
5DriversGoodGrowth drivers are limited, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
The stock shows potential but faces challenges in growth consistency and profitability metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100